The status of epidermal growth factor receptor and topoisomerase IIα genes in triple-negative breast cancer cells
The paper gives the results of studying the genes of epidermal growth factor receptor (EGFR) and topoisomerase IIα (TOP IIα) in patients with triple-negative breast cancer (BC). It is suggested that the lack of EGFR gene amplification might serve as a factor of good prognosis. TOP IIα gene amplifica...
Main Authors: | D. A. Karseladze, I. V. Poddubnaya, A. I. Karseladze |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/266 |
Similar Items
-
Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas
by: Arathi A Changavi, et al.
Published: (2015-07-01) -
Inhibition of topoisomerase IIα and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives
by: Sarunya Kitdumrongthum, et al.
Published: (2020-07-01) -
Topoisomerase IIα prevents ultrafine anaphase bridges by two mechanisms
by: Simon Gemble, et al.
Published: (2020-05-01) -
Interactions with topoisomerase IIa enhance the unwinding activity of the BLM helicase on recombination substrates and are necessary for preventing chromosome breakage
by: Russell, Beatriz
Published: (2009) -
Epidermal growth factor receptor (EGFR) overexpression in triple-negative breast cancer: association with clinicopathologic features and prognostic parameters
by: Atif Ali Hashmi, et al.
Published: (2019-02-01)